Telbivudine (Sebivo) in patients with hepatitis B virus (HBV) chronic infection
Hepatitis B is the most common serious liver infection in the world, with about 350 million people who are infected with the hepatitis B virus (HBV) and about 1 million deaths annually. Hepatitis B is characterized by an acute and a chronic phase, if the subject fails to produce adequate immune resp...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SEEd Medical Publishers
2008-01-01
|
| Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/238 |